🔴 Immediate Domain 1 — Physical
Symptom Burden & Medication Needs
Inadequately controlled symptoms: Dyspnea (only partially corrected on 3 L O₂). Pain from foot ulcer/osteomyelitis not documented — likely present and undertreated.
Undocumented physical needs: Nutritional status (poor wound healing in diabetes correlates with protein-calorie deficiency). Pressure area assessment for immobilised patient. Contralateral foot skin integrity. Bowel/bladder function if mobility restricted.
Medication needs: Enoxaparin (pending renal function — must not delay >2–4 hours once eGFR confirmed). IV antibiotics with bone penetration. Conversion from sliding-scale to basal-bolus insulin. Analgesia not yet addressed in plan.
🔴 Immediate Domain 2 — Psychological & Emotional
Distress, Fear, and Coping
No psychological or emotional assessment documented in the SOAP note. A 53-year-old woman experiencing acute breathlessness with a suspected life-threatening clot, on top of a non-healing infected foot, faces compounding fear: fear of dying from PE, fear of amputation, fear of losing function. None of these fears are documented as having been acknowledged or screened for.
Gap: No distress screening, no acknowledgment of psychological burden, no chaplaincy or social-emotional support mentioned.
🟡 Short-term Domain 3 — Social & Relational
Support Network & Caregiver Status
Completely absent from documentation. In a rural Indian context this is critical: who accompanied the patient? Who is primary decision-maker if she deteriorates? Are there children, a spouse, extended family? Who will manage wound care after discharge? Caregiver literacy about diabetes and wound management is unknown. Rural distance may limit family visits and follow-up compliance.
🟡 Short-term Domain 4 — Functional & Rehabilitative
Activities of Daily Living & Rehabilitation Goal
Pre-admission functional baseline not documented. Current mobility is almost certainly impaired (bilateral foot pathology + acute dyspnea). No physiotherapy, occupational therapy, or dietitian referral documented. The patient needs a formal functional assessment to plan realistic rehabilitation. Has the patient been asked what recovery means to her?
🔴 Immediate Domain 5 — Informational & Health Literacy
Informed Consent & Disease Understanding
The diagnosis of PE has not yet been confirmed (CTPA pending) but anticoagulation is being initiated. Patient's understanding of why she is receiving blood-thinning injections, the bleeding risks, and what CTPA involves is undocumented. Glycemic management failure over 12 years suggests either poor health literacy, inadequate education, socioeconomic barriers, or an unsupported insulin regimen — all unaddressed in the plan. Language and literacy level unknown.
🟡 Short-term Domain 6 — Spiritual, Cultural & Existential
Goals of Care & Meaning
Not documented. Given the severity and the setting (rural medical college in Nepal/India border region), cultural and religious beliefs may significantly shape what this patient wants from care — including views on amputation, blood products, and end-of-life preferences. A goals-of-care conversation has not been held. If she deteriorates acutely overnight, the team does not know what she would want.
🟢 Long-term Domain 7 — Environmental & Safety
In-Hospital Safety & Discharge Environment
In-hospital: Fall risk elevated (acute dyspnea + foot pathology + possible hypotension). Delirium prevention not mentioned. Nutritional monitoring likely absent. Pressure area care for immobilised patient undocumented.
Discharge: Home environment entirely unknown. Rural living likely means limited access to dressing supplies, podiatry, endocrinology follow-up, or laboratory monitoring. Discharge readiness framework not in place.
🟡 Short-term Domain 8 — Systems, Navigation & Advocacy
Access, Cost Barriers & Advocacy Gaps
CTPA, if available at this institution, may carry out-of-pocket costs the family cannot meet. Enoxaparin in India requires refrigeration and skilled injection technique — both may be barriers post-discharge. Endocrinology consult may not exist at a rural medical college. Orthopedic/vascular surgical capacity for osteomyelitis debridement needs confirmation. No social worker mentioned. The patient's silence in the documentation may reflect cultural deference rather than absence of need.
PICO Question 1 — Anticoagulation Without CTPA Confirmation
P: Adults with clinically suspected PE (acute hypoxia, clear CXR, elevated D-dimer) in resource-limited settings where CTPA is unavailable
I: Empirical therapeutic anticoagulation initiated without imaging confirmation
C: Withholding anticoagulation until imaging is confirmed
O: 30-day mortality, recurrent VTE, major bleeding
Evidence Summary
Clinical prediction tools (Wells Score, Geneva Score) combined with elevated D-dimer carry sufficient pre-test probability to justify empirical anticoagulation when imaging is unavailable. ESC 2019 PE Guidelines support this for intermediate-high probability cases. This patient's Wells Score is ≥5 (alternative diagnosis less likely than PE + HR>100 = high probability without DVT). GRADE certainty: Moderate — evidence derives from cohort data extrapolated from high-resource settings.
Effect in Plain Numbers
In high-probability clinical PE without anticoagulation: 30-day mortality ~15–25% (observational). With anticoagulation: ~2–8%. Absolute risk reduction approximately 12–17 lives per 100 patients. NNT ≈ 6–8. This is a high-magnitude, time-critical benefit.
Three-Circle Integration
Research: strong signal for treat empirically. Clinical expertise: confirm Wells ≥5 clinically before administering. Patient values: anticoagulation with a concurrent infected wound creates real bleeding risk — discuss this tradeoff at the bedside before first dose.
PICO Question 2 — Antibiotic Choice in Diabetic Foot Osteomyelitis
P: Adult with confirmed osteomyelitis (distal phalanx) complicating a diabetic foot ulcer
I: Broad-spectrum IV antibiotics with proven bone penetration (piperacillin-tazobactam, or fluoroquinolone + anti-MRSA agent)
C: Narrow-spectrum agents or oral antibiotics at initiation
O: Remission of osteomyelitis, avoidance of amputation, bacteremia clearance
Evidence Summary
IDSA 2012 Diabetic Foot Infection guidelines (updated 2023) recommend empirical broad-spectrum IV therapy covering Gram-negatives, anaerobes, and MRSA when systemic infection is present. Fluoroquinolones (ciprofloxacin/levofloxacin) have good bone penetration and oral bioavailability but increasing resistance limits empirical use. In an Indian setting MRSA prevalence is high; vancomycin + piperacillin-tazobactam is a reasonable empirical choice where cultures are pending. GRADE certainty: Moderate
Surrogate Warning
Most osteomyelitis trials use "remission" at 6 months as the outcome — a surrogate for the patient-important outcome of amputation avoidance and functional foot preservation. Evidence for long-term amputation-free survival is Low certainty.
PICO Question 3 — Basal-Bolus vs. Sliding Scale Insulin in Hospital
P: Hospitalised adult with uncontrolled T2DM (RBG 108–514 mg/dL)
I: Structured basal-bolus insulin regimen
C: Reactive sliding-scale insulin
O: Mean glucose, hypoglycemia events, infection outcomes, wound healing
Evidence Summary
The RABBIT-2 trial (Umpierrez et al. 2007, Diabetes Care) demonstrated that basal-bolus regimen (glargine + glulisine) achieved significantly better glucose control vs. sliding scale (mean glucose 166 vs 193 mg/dL) with lower composite complications without increased severe hypoglycemia. GRADE certainty: High for glucose control; Moderate for clinical infection outcomes.
Effect in Plain Numbers
Basal-bolus reduces post-prandial hyperglycemic excursions by approximately 27 mg/dL on average. In wound-healing contexts, maintaining glucose <180 mg/dL reduces surgical site infection risk by ~35% (relative). NNT for complication avoidance ≈ 8–10. At this facility: does insulin glargine exist in formulary? Alternatives if not are addressed in the Global Health module below.
Critical Awareness Debrief (Step 45.10)
- CA1The PE diagnosis is presumed not confirmed — all EBM evidence above applies to confirmed PE. The moment CTPA is done (or definitively unavailable), re-apply the evidence with the actual diagnosis, not the working hypothesis.
- CA2D-dimer elevation in the thousands is being interpreted as PE signal — it is equally valid as a sepsis/inflammation signal. The pre-test probability tools (Wells) are the corrective lens; make sure the team scores Wells formally, not gestalt.
- CA3RABBIT-2 trial data is from a US academic setting — insulin glargine availability in rural India is limited. The EBM translates, but the formulation may require adaptation (NPH insulin as basal substitute is the evidence-based alternative in LMIC settings).
Stage 2 — Local Resource Ceiling Table
| Resource | Plan Assumed | Local Reality (Rural MC) | Severity |
|---|
| CTPA | STAT availability | Likely unavailable or requires transfer | Not Available |
| Echocardiogram | To assess RV strain | Operator-dependent, not 24/7 | Referral/Delay |
| Enoxaparin (LMWH) | Standard formulary | May be available; verify stock | Slower |
| Insulin Glargine | Basal-bolus protocol | Often unavailable; NPH is substitute | Substitute Available |
| Orthopedic Surgeon | Urgent debridement | May not be on-site; visiting schedule | Referral Dependent |
| Endocrinology Consult | Recommended | Not available at rural MC | Not Available |
| Blood Cultures | Standard pre-antibiotic | Likely available; delay risk | Slower |
| Troponin / BNP | PE severity stratification | Often unavailable | Not Available |
| Vascular Surgery | If limb salvage needed | Tertiary referral only | Tertiary Only |
Highest-consequence gap: Absence of CTPA forces empirical anticoagulation — which simultaneously creates risk in a patient with an infected, potentially surgically amenable wound. This single gap cascades into every downstream safety decision in this case.
Stage 4 — Substitutes & Workarounds (Test-by-Test)
CriticalCTPA → Clinical + Wells + Bedside Echo (if available)
Substitute
Wells Score (formal calculation) + respiratory response to O₂ + clinical exam + any available portable US for RV assessment
Limitation vs. Gold Standard
Clinical probability tools have sensitivity ~83%, specificity ~50% — significant miss rate for small or sub-massive PE
Safety Threshold: If Wells ≥5 + D-dimer markedly elevated + SpO₂ does not improve with O₂ ≥6 L/min → empirical anticoagulate and arrange urgent transfer for CTPA. Do not continue empirical management beyond 48 hours without imaging confirmation.
ImportantInsulin Glargine → NPH Insulin (Intermediate-acting)
Substitute
NPH 0.3 units/kg at bedtime as "basal"; regular insulin with meals as "bolus" — a validated LMIC adaptation of basal-bolus
Limitation
NPH has unpredictable peak at 4–8 hours; higher nocturnal hypoglycemia risk than glargine; requires glucose check at 2–3 AM initially
Safety Threshold: Any RBG <70 mg/dL requires protocol adjustment and review. If glucose >400 persists >12 hours despite NPH-based regimen, switch to IV insulin infusion protocol.
ImportantOrthopedic Surgeon → General Surgeon + Wound Care Team + Antibiotics
Substitute
General surgery consult for initial debridement if orthopaedics unavailable; aggressive wound care; wound swab + bone biopsy attempt if feasible
Limitation
Phalangeal osteomyelitis with abscess requires bone-level debridement — general surgery without orthopedic training may achieve incomplete source control
Safety Threshold: If wound shows spreading cellulitis, new systemic signs of sepsis, or failure to improve in 48–72 hours → mandatory transfer to tertiary centre for orthopedic intervention regardless of distance or cost.
CriticalTroponin/BNP (PE Severity) → Clinical Hemodynamic Assessment
Substitute
Serial BP, HR, oxygen requirement trend, JVP assessment, and clinical signs of RV failure (raised JVP, hypotension, tachycardia progression)
Limitation
Clinical assessment misses early subclinical RV strain; no quantification of clot burden
Safety Threshold: New hypotension (SBP <90), HR >120, or SpO₂ falling despite ≥8 L O₂ = massive/sub-massive PE requiring emergency referral for thrombolysis or interventional therapy. This is not manageable at a rural MC.
Stage 5 — Ceiling-Aware Empirical Management Plan
Phase 1 — Hour 0–4 (All locally executable)
1. Stat creatinine/eGFR (confirm available in lab)
2. Formal Wells Score calculation (documented in notes)
3. If Wells ≥5 + eGFR >30: Enoxaparin 1 mg/kg SC stat
4. Blood cultures ×2 before antibiotics (if not already taken)
5. IV piperacillin-tazobactam 4.5 g q8h (or local equivalent with bone penetration)
6. O₂ titration to SpO₂ ≥94%
7. NPH insulin initiation: 0.3 units/kg bedtime dose; pre-meal regular insulin
8. Bedside patient explanation (5 minutes, in patient's language, family present)
Phase 2 — Hour 4–24
1. Surgical consult (general surgery if orthopedic unavailable) for wound assessment
2. Glucose monitoring q4h; adjust insulin per response
3. Serial vitals q2h — watch for hemodynamic deterioration
4. CTPA referral arranged (patient/family counselled on transfer need, costs addressed with social worker if available)
5. Document goals-of-care conversation: escalation wishes if she deteriorates
Exit Criterion — When Empirical Local Plan Has Failed
Mandatory tertiary transfer if: SBP <90 OR SpO₂ <90% on ≥8 L O₂ OR spreading limb infection at 48h OR glucose not controllable with NPH regimen. This list is the clinical safety net — it must be written in the notes and communicated to nursing staff tonight.
Stage 7 — Missed Low-Cost Clues (Zero-Cost, High-Yield)
- LC1Left foot status: Described as "bandaged" — what is underneath? Bilateral diabetic foot disease changes infection source assessment, DVT risk stratification, and surgical planning. A 30-second physical exam is the substitute for advanced imaging of the contralateral limb.
- LC2Fever / temperature: Not documented. In a case being worked up for PE vs. septic emboli from osteomyelitis, the presence or absence of fever is a zero-cost discriminator that belongs in every set of vitals.
- LC3Duration and character of dyspnea: Sudden onset vs. gradual worsening differentiates embolic event from evolving sepsis/ARDS. Not documented. This history is obtainable at the bedside in 2 minutes.
- LC4JVP assessment: A clinical marker of right heart strain — the free substitute for echo and BNP in this setting. Documented nowhere in the SOAP note.
- LC5Pleuritic chest pain: Classic PE symptom. Its presence or absence is a zero-cost pre-test probability modifier. Not asked or documented.
Stage 8 — System-Level Critical Awareness
- S8.1Shortcuts to unlearn: Empirical anticoagulation without imaging is appropriate here, but this pattern normalised over time creates a facility culture where PE is never imaged — which leads to missed alternative diagnoses and missed sub-massive cases needing thrombolysis. The habit needs a formal audit trigger.
- S8.2Silent failure risk: NPH insulin can cause nocturnal hypoglycemia with no warning symptom in a sleeping, dyspneic patient — this is the most likely way the glycemic substitution plan fails silently and causes harm before morning rounds.
- S8.3Strongest criticism of this approach: An anticoagulated patient with an infected, debrided wound is being managed at a facility without surgical backup, imaging confirmation, or hemodynamic monitoring infrastructure. The empirical plan is clinically sound but the safety margin is thin — transfer should be the default, not the exception, for a case this complex.
- S8.4Irreducible uncertainty: Whether this is PE or septic emboli cannot be resolved without CTPA. The clinical management overlaps significantly (antibiotics, source control) but anticoagulation in septic emboli from endocarditis carries specific risks not present in bland PE. This ambiguity cannot be managed away — it must be named in the handover.
Structural gap for escalation: A rural medical college in India managing poly-crisis cases (PE + osteomyelitis + uncontrolled T2DM) without on-site CTPA, orthopedic surgery, or endocrinology represents a system-level gap that exceeds individual case management. This case should be flagged to hospital administration as evidence that CTPA or a formal rapid-transfer pathway to a tertiary centre is required as a facility-level resource — not absorbed silently into the care of this one patient.
URGENT
Patient: 53F, DM ×12 years. Admitted: suspected PE + osteomyelitis R great toe + uncontrolled T2DM.
Two most urgent unmet needs:
(1) Anticoagulation status: Confirm Enoxaparin has been given — check notes for eGFR result and first dose time. If not yet administered, this is the immediate action.
(2) Patient has not been informed of working diagnosis or treatment rationale in her own language — before morning rounds, confirm this conversation has happened.
Not yet assessed: Psychological/emotional state; goals of care; left foot detailed exam; JVP; fever documented; family support network.
Non-negotiable escalation triggers tonight: SBP <90 | SpO₂ <90% on ≥8L O₂ | spreading cellulitis | nocturnal hypoglycemia (2–3 AM glucose check mandatory on NPH).
CTPA pending / not yet confirmed available. Diagnosis of PE remains presumed. Septic emboli from osteomyelitis remains on differential. Name this ambiguity at handover.